Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Implementation of an innovative hospital at home program for patients with hematalogic malignancies

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPeter C. ChangMMMegan MelodyDSDavid M. Swoboda

Discussion

Loading...

Member takes

Overview

Pilot program improves patient outcomes in hematologic malignancies, suggesting a shift in healthcare delivery.

Key Points

  • The aim is to evaluate the effectiveness of a Hospital at Home program for patients with hematologic malignancies undergoing induction chemotherapy.
  • Initiated a HaH program at a tertiary academic cancer institute.
  • Eligible patients were screened using specific clinical criteria.
  • Continuous biometric monitoring and home care services were provided to enrolled patients.
  • 36 out of 77 screened patients transitioned to HaH (46.8%).
  • Median inpatient length of stay for enrolled patients was 5 days, saving 183 inpatient bed-days.
  • 30-day mortality was 0% and readmissions were lower compared to traditional programs.

Cite This Study

Chang et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d1dfhttps://doi.org/10.1182/blood-2025-520
View Full Paper
Ask AI
Bookmark
Share